Fatih Mehmet Azik

Fatih Mehmet Azik

Auto-generated profile, based on publicly available information

Fatih Mehmet Azik

Department of Pediatric Hematology-Oncology, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla, Turkey

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2015 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
OEOn Behalf Of The Inborn Errors Working Party Of Ebmt
On Behalf Of The Inborn Errors Working Party Of Ebmt
SASusanne E. Aydin
Susanne E. Aydin
SKSara Sebnem Kilic
Sara Sebnem Kilic
CACaner Aytekin
Caner Aytekin
AKAshish Kumar
Ashish Kumar
MAMichael H. Albert
Michael H. Albert

17 January 2012 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
AMAyse Metin
Ayse Metin
BTBetul Tavil
Betul Tavil
FAFatih Azik
Fatih Azik
DADilek Azkur
Dilek Azkur
IOIkbal Ok‐Bozkaya
Ikbal Ok‐Bozkaya
DUDuygu Uckan
Duygu Uckan

1 August 2019 in Pediatrics & Neonatology
Verified
Journal Article
Open access
TGTülin Güngör
Tülin Güngör
ÖBÖzlem Arman Bilir
Özlem Arman Bilir
VÇVildan Koşan Çulha
Vildan Koşan Çulha
AGAli Güngör
Ali Güngör
AKAbdurrahman Kara
Abdurrahman Kara
HYHüsniye Neşe Yaralı
Hüsniye Neşe Yaralı
Immune thrombocytopenic purpura (ITP) is the most common cause of acquired thrombocytopenia children. The aim of this retrospective study is to describe presenting features and clinical characteristics of ITP and evaluate clinical course, treatment modalities, and complications and determine the effects of preceding infection history, age, gender, treatment modality, and admission platelet count on chronicity. Two hundred and eleven patients who were diagnosed ITP and followed-up in Department of Pediatric Hematology, Ankara Children Hematology Oncology Education and Research Hospital between January 2008 and September 2012 were included. Age of the patients, gender, date of admission, date of diagnosis, complaint in the application, previous infection and laboratory tests were recorded. Mean age of the patients on diagnosis was 5.4 ± 4.1 years. The female/male ratio was 1.03. The clinical courses were determined as acute or chronic in 72% and 28% of patients respectively. Mean age at diagnosis was significantly higher in chronic ITP (p < 0.01). Chronic course was significantly higher in female patients (p < 0.05). The most frequent complaint was bruises on the skin (68%). The most common physical examination findings were petechiae, purpura and ecchymosis (89%). Patients with a history of past infection (53.6%) and who had serologically positive infection (15.6%) frequently had acute course (p < 0.01). The most common serologically positive infection was Rubella. The mean platelet count was significantly higher in chronic ITP (p < 0.01). In the initial treatment of patients admitted in the acute phase, megadose methylprednisolone (MDMP) was used in 31% of patients, intravenous immune globulin (IVIG) in 55% of patients and anti-D in 2% of patients while 12% did not receive any treatment. There were no significant differences between the recurrence rate and treatment modality (p > 0.05). In our study, in females and in patients without any history of past infection, platelet count >20 × 109/L and initial diagnosis age > 10 years were found to increase the probability of chronic disease, which is compatible with the literature.

7 May 2014 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
FAFatih Azik
Fatih Azik
AEArzu Yazal Erdem
Arzu Yazal Erdem
BTBetül Tavil
Betül Tavil
CBCengiz Bayram
Cengiz Bayram
BTBahattin Tunç
Bahattin Tunç
DUDuygu Uçkan
Duygu Uçkan

17 May 2012 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
POPinar Oner
Pinar Oner
OOOzgur Oner
Ozgur Oner
FAFatih Azik
Fatih Azik
ECEsra Cop
Esra Cop
KMKerim M Munir
Kerim M Munir

1 September 2009 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
TITalia Ileri
Talia Ileri
FAFatih Azik
Fatih Azik
MEMehmet Ertem
Mehmet Ertem
ZUZumrut Uysal
Zumrut Uysal
SGSevgi Gozdasoglu
Sevgi Gozdasoglu
Spinal cord compression due to extramedullary hematopoiesis is an extremely rare complication of thalassemia intermedia. No cases with this complication have been reported in the first decade of life, because masses of heterotropic marrow developed in patients as a result of continuous erythropoiesis. We report the 9-year-old patient suffering from thalassemia intermedia and presenting spinal cord compression. We also review the literature about treatment options, because there is no consensus about the optimal treatment of these patients. Our patient was successfully treated with radiation therapy followed by hydroxyurea. With this combination therapy, he had no recurrence during the 4-year follow-up period. Clinical awareness of this phenomenon with the early treatment is essential for optimizing the successful outcome.